A critical discovery in cancer research is emerging with the use of VHH fragments to reactivate dysfunctional p53. This vital tumor inhibitor protein is frequently lost in several forms of malignancies, leading https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research